Scientists are exploring leading-edge technologies that could transform how cancer is studied, detected and treated by catching it earlier, when it's more treatable and survival rates are highest.

A new review by researchers at Oregon Health & Science University’s Knight Cancer Institute and other universities highlights how advances in New Approach Methodologies and tissue engineering are ...

A new Lancet Oncology Commission highlights a growing "human crisis" in cancer care. Despite advances in treatment and ...

Over the past generation, advances in treating common cancers—breast, lung, melanoma, and gastrointestinal (GI)—have improved ...

Advances in systemic and local therapies are helping more live longer with liver cancer and move forward after treatment as ...

Iovance Biotherapeutics (($IOVA)) announced an update on their ongoing clinical study. Study Overview: Iovance Biotherapeutics is conducting a ...

University of Wisconsin’s Carbone Cancer Center recently announced a partnership with TAE Life Sciences, a company that ...

Iovance Biotherapeutics (($IOVA)) announced an update on their ongoing clinical study. Study Overview: Iovance Biotherapeutics is conducting a ...

Researchers present an overview of treatment and management strategies for patients with HR+/HER2+ breast cancer, including common adverse effects.

20 new anticancer therapeutics, two new devices, two minimally invasive tests, AI-based tools for early detection approved by FDA. (HealthDay News) — Progress in cancer research, including approval of ...

Sellas Life Sciences Group Inc. (NASDAQ:SLS) is a biotechnology company that develops novel cancer therapies. Its lead ...

Advances are reshaping treatment for small cell lung cancer, with immunotherapy and emerging options offering hope for longer survival and potential cures. Immunotherapy is changing treatment ...